International Pharma Congresses during Covid-19

Lorenzo Fanti, Legal Counsel, Novartis AG, Argentina
Gregor von Arx, Global Head Legal, Neuroscience & Estab. Meds., Novartis Pharma AG, Switzerland
Geraldine Benjamin, English Solicitor, Bailhache Labesse Trustees Ltd, UK
Lorenzo Fanti, Legal Counsel, Novartis AG, Argentina

Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response to the Covid-19 pandemic. Normally, the content and events at a physical international congress are designed to comply with the host country’s laws and regulations on the promotion of pharmaceutical products . In the event of a virtual, fully digital congress, it may not be so obvious which country is the host country from a legal & regulatory perspective. Pharmaceutical companies participating in international congresses must therefore assess the question of jurisdiction and applicable laws to proactively comply, and reactively, if required, to go through administrative and/or litigious proceedings eventually brought by health authorities or competitors alike.

Read full paper Subscribe to the IICJ
Argentina Switzerland Management Pharmaceutical January 2021 Vol.14, No. 54, Winter 2021

Lorenzo Fanti

More

Gregor von Arx

More

https://www.linkedin.com/in/gregor-von-arx-7b426b7/

Geraldine Benjamin

More

Lorenzo Fanti

More

Novartis Pharma AG

More

Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company. https://www.novartis.com/our-company

Novartis AG

More

Argentina Switzerland Management Pharmaceutical January 2021 Vol.14, No. 54, Winter 2021